home.aspx
 
EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...

Caring People

SHARESHARESHARE
For the last 20+ years Caring People has been committed to providing our clients with top notch healthcare in the comfort of their homes. We are a home healthcare agency servicing clients in New York, New Jersey and South East Florida. Providing nurses and home health aides to care for the elderly and disabled. All services are directed and supervised by Registered Nurses which allows us to provide the highest level of professional service and oversight available.
SHARESHARESHARE

RELATED NEWS


Electric fields and light, two types of electromagnetism, are often monitored when researchers study brain function. However, most methods for measuring these phenomena in the brain are very invasive. Engineers at the Massachusetts Institute of Technology have devised a new technique to detect either electrical activity or optical signals in the brain using a minimally invasive sensor for magnetic resonance imaging (MRI). MRI is often used to measure changes in blood flow that indirectly represe...

READ MORE

Roche’s Tecentriq was the third PD-1/PD-L1 inhibitor to reach the market but is the first in class to be approved for any form of breast cancer. PD-L1 inhibitor Tecentriq (atezolizumab) has been cleared by the FDA for advanced triple-negative breast cancer (TNBC), in combination with Celgene’s chemotherapy drug Abraxane (nab-paclitaxel), in patients with locally advanced or metastatic PD-L1-positive tumors. The green light comes after a six-month priority review by the FDSA and is a ...

READ MORE

A new clinical practice guideline is the first from the American Academy of Sleep Medicine to provide comprehensive, evidence–based analyses of individual agents commonly used in the treatment of chronic insomnia disorder....

READ MORE

An £84.2m record fine from the Competition & Markets Authority for pharmaceutical funny business is no laughing matter, even to a giant of the industry like Pfizer. It’ll take more than a few bottles of its signature Viagra to pay that sort of sum, but pay it Pfizer should....
INDEPENDENT.CO.UK
READ MORE

The government has finally published its long-awaited response to the Accelerated Access Review, with plans for a new Accelerated Access Pathway that will open a new channel providing patients with faster access to the most innovative medicines and technologies....

READ MORE

After months of wrangling, the EMA finally has a solution to the £500 million financial liability it has faced over the tenancy to its former home in Canary Wharf. The EU regulator – now based in temporary accommodation in Amsterdam – has sub-let the entire 284,704 square feet (26,450 m2)accommodation at 30 Churchill Place to WeWork, a fast-growing shared office-space group. As a result of the deal, the EMA has also now settled its litigation with the Canary Wharf Group. Faced ...

READ MORE

EVENTS

The Digital Pharma Advances
THE DIGITAL PHARMA ADVANCES
January 29-29, 2020
Powerfully Target & Engage HCPs & Patients & Deliver Real-World Results With Integrated, Innovative Digital Strategies.Customer-Centric, Value-Adding, Multi-Channel Digital Pharma Marketing Strategies.

4th Annual Microbiome Movement, Drug Development, Europe
4TH ANNUAL MICROBIOME MOVEMENT, DRUG DEVELOPMENT, EUROPE
February 04-05, 2020
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effecti...